GPX Embolic Device
Peripheral vessel occlusion (Tumor embolization, devascularization)
Key Facts
About Fluidx Medical Technology
Fluidx Medical Technology is a clinical-stage medical device company pioneering next-generation embolic technologies for minimally invasive procedures. Its core innovation is the GPX Embolic Device, a durable liquid embolic designed for deep, distal vessel occlusion, currently under investigation in a pivotal trial with enrollment targeted for completion in January 2026. The company is led by a seasoned team of medtech entrepreneurs and industry veterans, aiming to address significant unmet needs in interventional oncology, particularly for tumor devascularization, and other peripheral embolization procedures. Fluidx operates as a pre-revenue, private entity advancing its product portfolio through clinical development.
View full company profile